{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:35:37Z","timestamp":1793190937917,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["024\/2016\/A1"],"award-info":[{"award-number":["024\/2016\/A1"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"publisher","award":["MYRG2015-00091-ICMS-QRCM"],"award-info":[{"award-number":["MYRG2015-00091-ICMS-QRCM"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"publisher","award":["MYRG2015-00101-ICMS-QRCM"],"award-info":[{"award-number":["MYRG2015-00101-ICMS-QRCM"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["SKLNMKF201605"],"award-info":[{"award-number":["SKLNMKF201605"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.taap.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T18:30:39Z","timestamp":1499884239000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Novel Hsp90 inhibitor platycodin D disrupts Hsp90\/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor"],"prefix":"10.1016","volume":"330","author":[{"given":"Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Jie","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Fang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-3120","authenticated-orcid":false,"given":"Jin-Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1158\/1541-7786.MCR-13-0605","article-title":"mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesis","volume":"12","author":"Acquaviva","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.taap.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrd2924","article-title":"Everolimus","volume":"8","author":"Atkins","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2017.07.006_bb0015","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/ijc.28880","article-title":"HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer","volume":"135","author":"Chen","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"e0129663","DOI":"10.1371\/journal.pone.0129663","article-title":"Rapamycin enhances the anti-cancer effect of dasatinib by suppressing Src\/PI3K\/mTOR pathway in NSCLC cells","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cbi.2013.07.002","article-title":"Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Ala and MAPK pathways","volume":"205","author":"Chun","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1126\/science.1124147","article-title":"Hypothalamic mTOR signaling regulates food intake","volume":"312","author":"Cota","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.taap.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"22030","DOI":"10.1074\/jbc.271.36.22030","article-title":"Physical interaction of mammalian CDC37 with CDK4","volume":"271","author":"Dai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.07.006_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","article-title":"Mammalian caspases: structure, activation, substrates, and functions during apoptosis","volume":"68","author":"Earnshaw","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.taap.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcp.2014.05.011","article-title":"Targeting PI3K\/AKT\/mTOR pathway in non small cell lung cancer","volume":"90","author":"Fumarola","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2017.07.006_bb0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)80428-6","article-title":"Regulatory subunits of energy-dependent proteases","volume":"91","author":"Gottesman","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.taap.2017.07.006_bb0060","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1074\/jbc.274.25.17525","article-title":"The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes","volume":"274","author":"Grenert","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"Janne","year":"2015","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.taap.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1074-5521(03)00075-9","article-title":"Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90","volume":"10","author":"Jez","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.taap.2017.07.006_bb0075","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.taap.2017.07.006_bb0080","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1074\/jbc.M705052200","article-title":"c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway","volume":"283","author":"Jin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.07.006_bb0085","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.7314\/APJCP.2014.15.4.1745","article-title":"Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac. J. Cancer P."},{"key":"10.1016\/j.taap.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2015.01.003","article-title":"Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells","volume":"749","author":"Li","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/aps.2015.99","article-title":"Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells","volume":"36","author":"Li","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2017.07.006_bb0100","doi-asserted-by":"crossref","first-page":"37997","DOI":"10.1038\/srep37997","article-title":"Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2017.07.006_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2010.07.012","article-title":"Gymnastics of molecular chaperones","volume":"39","author":"Mayer","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2017.07.006_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2017.07.006_bb0115","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1093\/emboj\/17.16.4829","article-title":"ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo","volume":"17","author":"Panaretou","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.taap.2017.07.006_bb0125","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1128\/MCB.19.10.7203","article-title":"Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis","volume":"19","author":"Peruzzi","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ccr.2008.08.002","article-title":"Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis","volume":"14","author":"Powers","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0092-8674(00)80314-1","article-title":"Identification and structural characterization of the ATP\/ADP-binding site in the Hsp90 molecular chaperone","volume":"90","author":"Prodromou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.taap.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","article-title":"mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling","volume":"1","author":"Rodrik-Outmezguine","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.taap.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ab.2003.10.038","article-title":"High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity","volume":"327","author":"Rowlands","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2017.07.006_bb0150","first-page":"698","article-title":"Everolimus in patients with advanced follicular-derived thyroid cancer: results of a phase II clinical trial","volume":"102","author":"Schneider","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","article-title":"4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors","volume":"18","author":"She","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"20090","DOI":"10.1074\/jbc.273.32.20090","article-title":"P50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site","volume":"273","author":"Silverstein","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.07.006_bb0165","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdp060","article-title":"Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors","volume":"20","author":"Soria","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2017.07.006_bb0170","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1074\/jbc.M806715200","article-title":"The human Cdc37 center dot Hsp90 complex studied by heteronuclear NMR spectroscopy","volume":"284","author":"Sreeramulu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.07.006_bb0175","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1101\/gad.10.12.1491","article-title":"Mammalian p50(Cdc37) is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4","volume":"10","author":"Stepanova","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.taap.2017.07.006_bb0180","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/bjc.2011.349","article-title":"Rapid non-genomic signalling by 17 beta-oestradiol through c-Src involves mTOR-dependent expression of HIF-1 alpha in breast cancer cells","volume":"105","author":"Sudhagar","year":"2011","journal-title":"Brit. J. Cancer."},{"key":"10.1016\/j.taap.2017.07.006_bb0185","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2017.07.006_bb0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2017.07.006_bb0195","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1038\/sj.onc.1207114","article-title":"Heat-shock proteins as regulators of apoptosis","volume":"22","author":"Takayama","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2017.07.006_bb0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1749-8546-9-16","article-title":"Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells","volume":"9","author":"Tang","year":"2014","journal-title":"Chinas Med."},{"key":"10.1016\/j.taap.2017.07.006_bb0205","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2017.07.006_bb0210","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1126\/science.aaf5023","article-title":"Structural Biology Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase","volume":"352","author":"Verba","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.taap.2017.07.006_bb0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2017.07.006_bb0220","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1126\/science.286.5446.1888","article-title":"Posttranslational quality control: folding, refolding, and degrading proteins","volume":"286","author":"Wickner","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.taap.2017.07.006_bb0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/358169a0","article-title":"Hsp90 chaperones protein folding in vitro","volume":"358","author":"Wiech","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.taap.2017.07.006_bb0230","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.vaccine.2008.11.029","article-title":"Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen","volume":"27","author":"Xie","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.taap.2017.07.006_bb0235","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrm1492","article-title":"Pathways of chaperone-mediated protein folding in the cytosol","volume":"5","author":"Young","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2017.07.006_bb0240","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cell.2004.12.024","article-title":"Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone","volume":"120","author":"Zhao","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.taap.2017.07.006_bb0245","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2006.03.032","article-title":"Cholesterol-lowering effect of platycodin D in hypercholesterolemic ICR mice","volume":"537","author":"Zhao","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2017.07.006_bb0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7150\/jca.11291","article-title":"Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K\/Akt\/mTOR and MAPK signaling pathways","volume":"6","author":"Zhao","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.taap.2017.07.006_bb0255","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:19:03Z","timestamp":1589768343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17303034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":51,"alternative-id":["S0041008X17303034"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.07.006","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Hsp90 inhibitor platycodin D disrupts Hsp90\/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}